Category News

Genentech

Genentech Highlights Breakthrough Phase III Results for Gazyva in Autoimmune Kidney Disease

Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease Genentech, a member of the Roche Group announced today that the Phase III MAJESTY study in adults with primary membranous…

Read MoreGenentech Highlights Breakthrough Phase III Results for Gazyva in Autoimmune Kidney Disease
Promega

Promega Presents Breakthrough Cellular Target Engagement Platform at SLAS 2026

Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026 Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins.…

Read MorePromega Presents Breakthrough Cellular Target Engagement Platform at SLAS 2026
KalVista

KalVista Pharmaceuticals Showcases EKTERLY® Data at AAAAI 2026 Annual Meeting

KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals, Inc. today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI)…

Read MoreKalVista Pharmaceuticals Showcases EKTERLY® Data at AAAAI 2026 Annual Meeting
Galderma

Galderma Introduces First-of-Its-Kind “We Are All Sculptra” Campaign Showcasing Treatment Benefits

We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties Galderma the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine…

Read MoreGalderma Introduces First-of-Its-Kind “We Are All Sculptra” Campaign Showcasing Treatment Benefits
Health

Flatiron Health Appoints New Leaders for Business, Technology, and Product

Flatiron Health Names New Chief Business, Technology, and Product Leaders Flatiron Health is pleased to announce three significant appointments to its Executive Team, reflecting the critical, enterprise-level responsibilities these leaders have assumed and the company’s evolving direction. Michael Bierl will…

Read MoreFlatiron Health Appoints New Leaders for Business, Technology, and Product
Atlas

Atlas Oncology Partners Secures $28M Series A Funding to Expand Value-Based Cancer Care

Atlas Oncology Partners Raises $28M Series A to Scale Value-Based Oncology Care Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders, a healthcare investment firm focused on building and growing companies…

Read MoreAtlas Oncology Partners Secures $28M Series A Funding to Expand Value-Based Cancer Care
Thermo Fisher

Thermo Fisher Scientific Partners with Datavant to Expand Real-World Data Interoperability

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make…

Read MoreThermo Fisher Scientific Partners with Datavant to Expand Real-World Data Interoperability
Agilent

Agilent Honors Boehringer Ingelheim with First 2025 Instrument Trade-In Impact Award

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award Agilent Technologies Inc. today announced that Boehringer Ingelheim has been selected as the winner of Agilent’s inaugural Instrument Trade‑In Impact Award, recognizing exceptional sustainability leadership demonstrated through their participation in…

Read MoreAgilent Honors Boehringer Ingelheim with First 2025 Instrument Trade-In Impact Award